Related Experiment Video

Updated: Oct 25, 2025

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

11.9K

Hyperbilirubinemia in the Term Infant: Re-evaluating What We Think We Know

Cathy Hammerman1, Michael Kaplan2

  • 1Department of Neonatology, Shaare Zedek Medical Center; The Faculty of Medicine of the Hebrew University, Jerusalem, Israel.

Clinics in Perinatology
|August 6, 2021
PubMed

Insights

Neonatal hyperbilirubinemia presents a complex clinical challenge. While severe cases risk neurotoxicity, mild elevations may offer protective antioxidant benefits to newborns.

Area of Science:

  • Neonatology
  • Pediatric Neurology
  • Biochemistry

Background:

  • Neonatal hyperbilirubinemia is a common condition in newborns.
  • Bilirubin, a byproduct of heme breakdown, is typically cleared by the liver.
  • Elevated bilirubin levels (hyperbilirubinemia) can occur in term infants.

Purpose of the Study:

  • To review current understanding of neonatal hyperbilirubinemia.
  • To discuss controversial aspects of hyperbilirubinemia management.
  • To explore the dual role of bilirubin as both a potential neurotoxin and an antioxidant.

Main Methods:

  • Literature review of contemporary research on neonatal hyperbilirubinemia.
  • Analysis of studies on bilirubin neurotoxicity spectrum.
  • Examination of evidence for bilirubin's antioxidant properties.

Main Results:

  • Bilirubin neurotoxicity encompasses a broad range of clinical features.
  • Mild neonatal hyperbilirubinemia may confer antioxidant protection.
  • The clinical approach to hyperbilirubinemia requires careful consideration of these dual roles.

Conclusions:

  • The clinical management of neonatal hyperbilirubinemia should acknowledge its complex pathophysiology.
  • Further research is needed to fully elucidate the protective effects of mild hyperbilirubinemia.
  • A nuanced approach balancing risks and benefits is essential for optimal neonatal care.

Keywords:
BilirubinHyperbilirubinemiaNeurologic damageTerm infant

More Related Videos

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.1K
Biochemical Measurement of Neonatal Hypoxia13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.2K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
44
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
47
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
39
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
37
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
57